Connect with us

Hi, what are you looking for?

Monday, Dec 5, 2022
Mugglehead Magazine
Alternative investment news based in Vancouver, B.C.


Luxembourg health authorities visit Tilray Medical facilities in Portugal

Luxembourg health authorities visit Tilray Medical facilities in Portugal
Photo via Tilray

Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY) has been expanding its international presence over the last years and recently, the Luxembourg government visited its facility in Portugal.

On Wednesday, the cannabis company said it welcomed the Luxembourg Ministry of Health Delegation to the company’s European campus and facility located in Cantanhede, Portugal.

Tilray’s facility is EU-GMP-certified for medical cannabis cultivation and manufacturing and provides patients in Luxembourg and across Europe with safe and reliable access to high-quality medical cannabis.

Last November, supply issues were causing a shortage of medical pot, according to the country’s top health official.

In response to a parliamentary question, Health Minister Paulette Lenert said that by mid-month, the country had gone through two-thirds of the 13.5-kilogram medical pot shipment it received from Tilray the previous month.

Company stock went down Wednesday by 1.83 per cent to USD$0.06 on the Nasdaq Exchange.

Read more:  Tilray first company approved to sell medical cannabis in Portugal

Read more: Luxembourg short on medical pot after ‘supply problems’ with Tilray

“We are honoured to host the Luxembourg Ministry of Health Delegation at our state-of-the-art cannabis facility in Cantanhede, Portugal,” Tilray’s managing director in Europe Sascha Mielcarek, said.

“Demand for cannabis legalization in Europe is growing rapidly and we are incredibly proud to serve the patients in Luxembourg and around the world with the high-quality medical cannabis products they rely on and in the formats they prefer.”

Tilray is one of the first companies to become an approved licensed producer of medical cannabis in Canada to build one of the first GMP-certified cannabis production facilities in Europe, first in Portugal and later in Germany.

Its Tilray Medical is one of the biggest suppliers of medical cannabis brands in 20 countries and across five continents. The medical division includes Tilray Medical Canada, Tilray Medical Australia, Tilray Medical Australia-New Zealand and Tilray Medical Europe.

Follow Mugglehead on Twitter

Like Mugglehead on Facebook

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like


The company reported an international cannabis revenue of $10.4 million


Cannabis is highly regulated in Ireland and requires a Ministerial Licence


Its FL Group S.R.L. division received approval from the Ministry of Health for its cannabis oral solution THC25


A draft of the regulation will be presented in the upcoming months